On August 31, 2024, the A-share market completed the disclosure of financial reports for the first half of 2024, and 175 listed companies in Sichuan region submitted their "report cards" for the first half of the year. According to preliminary statistics, 175 Sichuan stock companies achieved a total operating revenue of 533.7 billion yuan and a net profit attributable to shareholders of 52.2 billion yuan in the first half of the year, of which 136 companies had a positive net profit attributable to shareholders.
Traditional industry advantages still exist
As a characteristic advantageous industry in Sichuan, Sichuan liquor continues to demonstrate excellent market competitiveness. Wuliangye ranked first on the profit list with a net profit attributable to its parent company of 19.057 billion yuan, a year-on-year increase of 11.86%, followed closely by Luzhou Laojiao with a net profit of 8.028 billion yuan.
The performance of these two companies is attributed to their good operating conditions. Pacific Securities analysis pointed out that in the second quarter of this year, Wuliangye not only demonstrated outstanding sales performance, but also optimized the product structure of its series of liquors, further enhancing its market competitiveness. In addition, the company's cash flow and contractual liabilities are good, and its financial management is stable.
As the first listed bank in Sichuan, Chengdu Bank has delivered a net profit of 6.167 billion yuan, ranking third on the Sichuan stock profit list.
In terms of operating revenue, the top 5 listed companies all exceed 40 billion yuan. Sichuan Changhong, Wuliangye, and New Hope ranked in the top three with revenues of 51.419 billion yuan, 50.648 billion yuan, and 49.577 billion yuan, respectively. Following closely behind are Sichuan Road and Bridge and Tongwei Shares.
The automobile manufacturing industry has become a highlight
The manufacturing industry in Sichuan saw a rebound in the first half of the year. Among the top ten listed companies in terms of net profit growth, 8 companies are from the manufacturing sector. Especially the two automobile manufacturing companies have achieved impressive growth performance.
The net profit growth rates of Xiling Power and Fulin Precision are 251.51% and 140.78% respectively, becoming the focus of market attention. Analysts believe that there are both reasons for market recovery and the transformation of the enterprise itself behind it. Taking Fulin Precision as an example, in the first half of the year, the new energy market rebounded, the demand for lithium iron phosphate increased, and the production capacity of Fulin Precision's cathode materials was efficiently utilized. In addition, the company also focuses on the fast charging market, with a surge in shipments of fast charging products. In the first half of the year, the company's production capacity, output, and loading volume have all increased, resulting in a significant increase in sales revenue.
The reporter found that although the overall performance remained stable, some companies faced certain challenges in the process of industrial transformation, with significant fluctuations in net profit. In the first half of the year, 28 listed companies in Sichuan experienced a net profit decline of over 100%. Among them, creative information has experienced a significant decline in net profit due to factors such as intensified industry competition and tightened customer budgets.
Steady growth in technology and pharmaceuticals
In emerging industries, technology and pharmaceutical companies have performed steadily. Many companies have achieved performance growth by leveraging their advantages in technology research and development, product innovation, and market expansion.
At the company level, listed companies in the software service industry such as Chengdian Dianxin, Yimikang, Guanxiang Technology, and Tangyuan Electric have achieved dual growth in operating revenue and net profit; In the pharmaceutical field, companies such as Chengdu Pioneer, Yuandong Biotechnology, Kanghong Pharmaceutical, Oukang Pharmaceutical, Kanghua Biotechnology, and Kelun Pharmaceutical have achieved excellent results through their deep cultivation and meticulous work in their respective fields.
Taking Chengdu Pioneer as an example, in the first half of the year, the company achieved more accurate market positioning and more efficient business operations through cross market resource sharing and complementary advantages. The overall performance of the company was stable, achieving a revenue of 195 million yuan, a year-on-year increase of 25.10%, and a net profit attributable to the parent company of 10.1977 million yuan, a year-on-year increase of 75.19%.